Vibecke Bondø will resign her position as the CEO of SalmoNor to take over as chair of the board of NTS ASA, according to a shareholder proposal set to be voted on at NTS’ annual general meeting on 29 April.
The proposal to elevate Bondø to the chairmanship of NTS came from “several shareholders” to the firm’s nomination committee, according to an 11 April note released by the company through the Oslo Stock Exchange.
“Bondø has led SalmoNor since 2010 and has broad board experience from NTS, NHO, Sjømat Norge, and several other companies,” the notice said. “The Bondø family is also NTS’ second-largest owner. She is thus resigning as CEO of the subsidiary SalmoNor both to ensure good corporate governance and free up time [for her to fill] the board chair job.”
"I am happy to be proposed as the new chairman of the board of NTS at a turning point. Nils Martin Williksen has done a formidable job as chairman of the board in recent months, and has managed the company with a steady hand in a complicated situation with [the] takeover bid and ownership dispute,” Bondø said. “I would also like to take this opportunity to thank you skilled employees in SalmoNor for everything we have achieved over many years.
NTS Board Chair Nils Martin Williksen, who was elected as board chair in February 2022 after backing SalMar’s offer for the company, backed Bondø’s appointment to be his successor.
“Vibecke Bondø has led SalmoNor since 2010 and has delivered impressive results over a long period of time,” Williksen said. “The proposed changes will clarify Vibecke's ownership role at the same time as the proposal should also be a good one solution for SalmoNor and for the employees in the company.”
NTS' board of directors has also recommended SalmoNor Board Chair Paal E. Johnsen be named as board chair of Norway Royal Salmon, which is majority-owned by NTS. Under the proposal, Johnsen will be replaced as SalmoNor board chair by Rodo Invest AS Director Roald Dolmen, currently an NTS board member and a lead investor in land-based start-up Gaia Salmon. The proposal will be voted on at NRS’ extraordinary general meeting on 20 April.
Photo courtesy of NY Norge